OverviewSuggest Edit

Motus GI is a medical technology company dedicated to improving endoscopy outcomes and experiences. The Company is focused on bringing to market the Pure-Vu System which is designed to improve the colonoscopy experience and assist in the early detection and prevention of colorectal cancer and other diseases of the rectum and colon. The Pure-Vu System has the potential to improve the colonoscopy experience for physicians, patients and payers by diminishing the dependency on pre-procedural preparations, thereby enhancing the quality and cost-effectiveness of the exam.
TypePublic
Founded2010
HQNew Hope, PA, US
Websitemotusgi.com

Latest Updates

Employees (est.) (Feb 2019)39
Share Price (May 2022)$0.3(-10%)
Cybersecurity ratingBMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at Motus GI

David Hochman

David Hochman

Independent Director and Chairman
Andrew Taylor

Andrew Taylor

Chief Financial Officer
Sonja Nelson

Sonja Nelson

Independent Director and Financial Expert of the Audit Committee
Jeff Hutchison

Jeff Hutchison

Vice President, U.S. Sales & Commercial Operations
Scott C. Aldrich

Scott C. Aldrich

Vice President, Marketing & Strategy
Gary J. Pruden

Gary J. Pruden

Independent Director
Show more

Motus GI Office Locations

Motus GI has offices in New Hope and Fort Lauderdale
New Hope, PA, US (HQ)
150 Union Square Dr
Fort Lauderdale, FL, US
1301 E Broward Blvd #310
Show all (2)

Motus GI Financials and Metrics

Motus GI Revenue

USD

Market capitalization (10-May-2022)

13.8m

Closing stock price (10-May-2022)

0.3

Cash (31-Mar-2021)

27.7m

EV

(5.2m)
Motus GI's current market capitalization is $13.8 m.
Annual
USDFY, 2018FY, 2019FY, 2020

Cash

18.1m20.5m20.8m

Accounts Receivable

5.0k65.0k35.0k

Prepaid Expenses

930.0k448.0k

Inventories

23.0k1.0m805.0k
Quarterly
USDQ1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021

Cash

18.6m5.1m6.9m10.2m7.9m15.7m21.5m17.1m23.7m27.7m

Accounts Receivable

11.0k31.0k23.0k1.0k8.0k19.0k10.0k39.0k74.0k

Prepaid Expenses

938.0k862.0k1.2m1.0m902.0k537.0k1.2m1.0m889.0k1.2m

Inventories

21.0k81.0k46.0k115.0k93.0k771.0k1.2m1.3m1.3m770.0k
Annual
USDFY, 2018FY, 2019FY, 2020

Net Income

(22.3m)(23.1m)(19.3m)

Depreciation and Amortization

152.0k223.0k377.0k

Inventories

(381.0k)(975.0k)(621.0k)

Accounts Payable

744.0k629.0k(489.0k)
USDQ1, 2018

Financial Leverage

1.2 x
Show all financial metrics

Motus GI Cybersecurity Score

Cybersecurity ratingPremium dataset

B

83/100

SecurityScorecard logo

Motus GI Online and Social Media Presence

Embed Graph

Motus GI News and Updates

Motus GI to Release First Quarter Results and Provide a Business Update on May 12

FORT LAUDERDALE, Fla., April 28, 2022 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that improve clinical outcomes and enhance the cost-efficiency associated with the diagnosis and management of…

Motus GI Completes Enrollment in the European Union Feasibility Study of the Pure-Vu® System as a New Method for Bowel Cleansing in Patients with a History of Poor Bowel Preparation

FORT LAUDERDALE, Fla., April 21, 2022 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that improve clinical outcomes and enhance the cost-efficiency associated with the diagnosis and management of…

Motus GI Granted 180-Day Extension to Meet NASDAQ Minimum Bid Price Requirement

FORT LAUDERDALE, Fla., Feb. 24, 2022 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that improve clinical outcomes and enhance the cost-efficiency associated with the diagnosis and management of …

Motus GI to Host Innovation Day Highlighting the Pure-Vu EVS System

The innovation day is scheduled to start at 12:30 p.m. ET on Tuesday, January 25th The innovation day is scheduled to start at 12:30 p.m. ET on Tuesday, January 25th

Motus GI Announces U.S. Patent For The Pure-Vu® System's Automatic Self-Purging Features

Expanding patent portfolio extends first-mover advantage in the colonoscopy procedure market, estimated at close to 55M global procedures per year Expanding patent portfolio extends first-mover advantage in the colonoscopy procedure market, estimated at close to 55M global procedures per year

Motus GI Reports Third Quarter 2021 Financial Results and Provides Corporate Update

FORT LAUDERDALE, Fla., Nov. 12, 2021 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that improve clinical outcomes and enhance the cost-efficiency associated with the diagnosis and management of …
Show more

Motus GI Frequently Asked Questions

  • When was Motus GI founded?

    Motus GI was founded in 2010.

  • Who are Motus GI key executives?

    Motus GI's key executives are David Hochman, Andrew Taylor and Sonja Nelson.

  • How many employees does Motus GI have?

    Motus GI has 39 employees.

  • Who are Motus GI competitors?

    Competitors of Motus GI include Optim, Protaryx Medical and LenoMed.

  • Where is Motus GI headquarters?

    Motus GI headquarters is located at 150 Union Square Dr, New Hope.

  • Where are Motus GI offices?

    Motus GI has offices in New Hope and Fort Lauderdale.

  • How many offices does Motus GI have?

    Motus GI has 2 offices.